(Press-News.org) Contact information: Zuzana Dobbie
zuzana.dobbie_graf@roche.com
416-168-88268
Roche
Roche reports new method for efficiently transporting antibodies across the blood-brain barrier
Results published in Neuron demonstrate efficacy in preclinical mouse models of Alzheimer's disease
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models1. Roche Pharma Early Research and Development (pRED) scientists found that such enhanced transfer of antibodies through the BBB was associated with a marked improvement in amyloid reduction in the brain of a mouse model of Alzheimer's disease.
"Thanks to our sophisticated protein engineering we were able to design a system that exploits natural transport mechanisms to significantly increase the transfer of investigational antibodies into the brain in preclinical models," said Luca Santarelli, Head of Neuroscience, Ophthalmology and Rare Diseases at Roche pRED. "Using Roche's Brain Shuttle technology, the target engagement of investigational antibodies in the brain in a preclinical model was increased by over 50-fold compared to the parent antibody."
The BBB is a selective interface that restricts movement of molecules between the bloodstream and central nervous system. This barrier imposes a major challenge to the development of therapies for neurological diseases, in particular large molecules, due to the limited ability with which they can penetrate through the BBB. The study published in Neuron showed that the Roche Brain Shuttle acts by engaging the natural transferrin receptor (TfR) in a specific mode that triggers a process called receptor-mediated transcytosis to transport molecules into the brain.
"The efficacy of the Brain Shuttle technology in preclinical models suggests that this approach could deliver therapeutic molecules across the BBB. We will continue to investigate the potential of the Brain Shuttle technology to transport a variety of molecules such as growth factors, antibodies, peptides and oligonucleotides across the BBB," said Anirvan Ghosh, Head Neuroscience Discovery at Roche pRED.
"If we are able to clinically validate the preclinical results observed with the Brain Shuttle technology, it could lead us to a way to test investigational drugs in a variety of brain disorders," said Per-Ola Freskgard, the Preclinical Project Leader for this technology platform at Roche pRED.
###
About Neuroscience
Roche is working on developing molecular entities in neuroscience for a range of diseases including schizophrenia, multiple sclerosis, depression, neurodevelopmental disorders, Parkinson's disease and Alzheimer's disease. With one of the strongest neuroscience pipelines in the industry, and by working closely with academic institutions, biotech companies, and forming public-private partnerships, Roche's focus is on expanding its Neuroscience franchise to better serve patients.
About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, infectious disease, inflammation metabolism and neuroscience. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012, Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs ($9 billion US) in R&D. The Group posted sales of 45.5 billion Swiss francs ($48.4 billion US). Genentech, United States, is a wholly owned member of the Roche Group. Roche is the majority stake in Chugai Pharmaceutical, Japan. For more information: http://www.roche.com.
1Niewoehner et al., Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle, Neuron (2014), http://dx.doi.org/10.1016/j.neuron.2013.10.061
Roche reports new method for efficiently transporting antibodies across the blood-brain barrier
Results published in Neuron demonstrate efficacy in preclinical mouse models of Alzheimer's disease
2014-01-08
ELSE PRESS RELEASES FROM THIS DATE:
An improved, cost-effective catalyst for water-splitting devices
2014-01-08
An improved, cost-effective catalyst for water-splitting devices
Solar energy appears to be the only form of renewable that can be exploited at level that matches the world's growing needs. However, it is equally necessary to find efficient ways to store ...
New research: Effects of eating half an avocado with lunch on satiety & desire to eat between meals
2014-01-08
New research: Effects of eating half an avocado with lunch on satiety & desire to eat between meals
Loma Linda University study explores the relationship between avocado consumption, satiety and blood sugar
IRVINE, Calif. (DATE) – New research published in the ...
LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
2014-01-08
LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
Cranberry pills, estrogen and acupuncture also found to be helpful
LOS ANGELES (Jan. 8, 2014) – While ...
Researchers propose alternative way to allocate science funding
2014-01-08
Researchers propose alternative way to allocate science funding
Researchers in the United States have suggested an alternative way to allocate science funding. The method, which is described in EMBO reports, depends on a collective distribution of funding by ...
Medicine protects against strokes
2014-01-08
Medicine protects against strokes
It is well-known that anticoagulant medicine assists in the prevention of strokes. A large Danish study now shows that the medicine can also reduce the risk of death and brain damage when a stroke happens ...
Seniors moving to HCBS face more hospital risk
2014-01-08
Seniors moving to HCBS face more hospital risk
PROVIDENCE, R.I. [Brown University] — Seniors want greater access to home- and community-based long-term care services. Medicaid policymakers have been happy to oblige with new programs to help people move out of expensive ...
Chemical imaging brings cancer tissue analysis into the digital age
2014-01-08
Chemical imaging brings cancer tissue analysis into the digital age
A new method for analysing biological samples based on their chemical makeup is set to transform the way medical scientists examine diseased tissue.
When tests are carried out on a patient's tissue ...
Climate change: How does soil store CO2?
2014-01-08
Climate change: How does soil store CO2?
Carbon content in soil influences climate models
Previous studies have established that carbon binds to tiny mineral particles. In this latest study, published in Nature Communications, researchers have shown ...
COPD: DMP is largely consistent with guidelines
2014-01-08
COPD: DMP is largely consistent with guidelines
Current guidelines are more detailed regarding some aspects of treatment
On 3 January 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results ...
Study shows 'readability' scores are largely inaccurate
2014-01-08
Study shows 'readability' scores are largely inaccurate
Teachers, parents and textbook companies use technical "readability" formulas to determine how difficult reading materials are and to set reading levels by age group. But new research from North Carolina ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Roche reports new method for efficiently transporting antibodies across the blood-brain barrierResults published in Neuron demonstrate efficacy in preclinical mouse models of Alzheimer's disease